June 18, 2010, Newsletter Issue #76: The promise of Bextra
Tip of the Week
A new class of anti-inflammation drugs called COX-2 inhibitors such as Bextra held out great promise of pain relief, especially for patients who developed bleeding ulcers and other gastrointestinal problems from taking older anti-inflammatories like asprin or ibuprofen. Unfortunately, Bextra has been found to cause increased risks of cardiovascular problems with long-term use. In a report releasetd in February of 2005, the FDA also noted reports of serious and potentially life-threatening skin reactions in patients using Bextra. The FDA further found that the advantages of Bextra did not significantly outweigh those of traditional nonsteroidal anti-inflammatory drugs.
About LifeTips
Now one of the top on-line publishers in the world, LifeTips offers tips to millions of monthly visitors. Our mission mission is to make your life smarter, better, faster and wiser. Expert writers earn dough for what they know. And exclusive sponsors in each niche topic help us make-it-all happen.
